Dr. Florian Märkl

Dr. Florian Märkl is Head of Discovery at Plectonic Biotech, leading the identification of novel targets and the hit-to-lead optimization of DNA origami-based T cell engagers. With deep expertise in T cell engineering and immuno-oncology, he drives innovation at the interface of discovery and translational research, advancing new therapeutic candidates and expanding Plectonic’s technology platform. Florian earned his Ph.D. in Medical Research from Ludwig-Maximilians-Universität München, where he developed a modular T cell and bispecific antibody platform for cancer immunotherapy.